相似文献
1
Candida auris‒Associated Hospitalizations, United States, 2017-2022.
Emerg Infect Dis. 2023 Jul;29(7):1485-1487. doi: 10.3201/eid2907.230540.
2
CDC: Candida auris Fungal Infections and Drug Resistance on the Rise.
JAMA. 2023 Apr 18;329(15):1248. doi: 10.1001/jama.2023.5255.
3
Novel Intravenous Immunoglobulin Therapy for the Prevention and Treatment of Candida auris and Candida albicans Disseminated Candidiasis.
mSphere. 2023 Feb 21;8(1):e0058422. doi: 10.1128/msphere.00584-22. Epub 2023 Jan 23.
4
Nationwide Outbreak of Candida auris Infections Driven by COVID-19 Hospitalizations, Israel, 2021-2022.
Emerg Infect Dis. 2023 Jul;29(7):1297-1301. doi: 10.3201/eid2907.221888.
5
Review of treatment options for a multidrug-resistant fungus: Candida auris.
Med Mycol. 2024 Jan 9;62(1). doi: 10.1093/mmy/myad127.
6
The first invasive infection in Taiwan.
Emerg Microbes Infect. 2022 Dec;11(1):1867-1875. doi: 10.1080/22221751.2022.2100280.
7
An Immunocompromised Mouse Model of Candida auris Systemic Infection.
Methods Mol Biol. 2022;2517:317-328. doi: 10.1007/978-1-0716-2417-3_25.
8
Dissemination of Candida auris to deep organs in neonatal murine invasive candidiasis.
Microb Pathog. 2021 Dec;161(Pt B):105285. doi: 10.1016/j.micpath.2021.105285. Epub 2021 Nov 10.
9
Current scenario of the search for new antifungal agents to treat Candida auris infections: An integrative review.
J Mycol Med. 2022 Mar;32(1):101232. doi: 10.1016/j.mycmed.2021.101232. Epub 2021 Dec 1.
10
Discovery of a new chemical scaffold for the treatment of superbug infections.
Emerg Microbes Infect. 2023 Dec;12(1):2208687. doi: 10.1080/22221751.2023.2208687.
引用本文的文献
1
Geographical variation in the clinical profile of patients with .
Antimicrob Steward Healthc Epidemiol. 2025 Jul 28;5(1):e163. doi: 10.1017/ash.2025.10064. eCollection 2025.
2
The calcineurin pathway regulates extreme thermotolerance, cell membrane and wall integrity, antifungal resistance, and virulence in Candida auris.
PLoS Pathog. 2025 Jul 28;21(7):e1013363. doi: 10.1371/journal.ppat.1013363. eCollection 2025 Jul.
3
Risk Factors for Among Admitted Patients in Riyadh, Saudi Arabia (2020-2022).
Infect Drug Resist. 2025 Jul 8;18:3369-3381. doi: 10.2147/IDR.S528127. eCollection 2025.
4
Managing fungemias: the results of a prospective and international study.
Antimicrob Agents Chemother. 2025 Aug 6;69(8):e0035825. doi: 10.1128/aac.00358-25. Epub 2025 Jun 25.
5
Population-Based Active Surveillance for Culture-Confirmed Candidemia - 10 Sites, United States, 2017-2021.
MMWR Surveill Summ. 2025 May 29;74(4):1-15. doi: 10.15585/mmwr.ss7404a1.
6
Invasive Candidiasis in the Intensive Care Unit: Where Are We Now?
J Fungi (Basel). 2025 Mar 27;11(4):258. doi: 10.3390/jof11040258.
7
Signaling pathways governing the pathobiological features and antifungal drug resistance of .
mBio. 2025 May 14;16(5):e0247523. doi: 10.1128/mbio.02475-23. Epub 2025 Apr 3.
8
isolates from New York outbreak are highly pathogenic with measurable experimental disease in .
Microbiol Spectr. 2025 Mar 4;13(3):e0294223. doi: 10.1128/spectrum.02942-23. Epub 2025 Feb 6.
9
The First Case of Detection and Infection Control in a Pediatric Bone Marrow Transplant Child Patient in Guangxi, China.
Infect Drug Resist. 2025 Jan 6;18:127-133. doi: 10.2147/IDR.S490696. eCollection 2025.
10
: Epidemiology and Antifungal Strategy.
Annu Rev Med. 2025 Jan;76(1):57-67. doi: 10.1146/annurev-med-061523-021233. Epub 2025 Jan 16.
本文引用的文献
1
Hospitalizations for Unspecified Mycoses in a Large Administrative Data Set and Implications for Fungal Disease Burden Estimates, United States, 2019-2021.
Open Forum Infect Dis. 2023 Feb 24;10(3):ofad100. doi: 10.1093/ofid/ofad100. eCollection 2023 Mar.
2
Worsening Spread of in the United States, 2019 to 2021.
Ann Intern Med. 2023 Apr;176(4):489-495. doi: 10.7326/M22-3469. Epub 2023 Mar 21.
3
Comparative Outcomes of Candida auris Bloodstream Infections: A Multicenter Retrospective Case-Control Study.
Clin Infect Dis. 2023 Feb 8;76(3):e1436-e1443. doi: 10.1093/cid/ciac735.
4
Treatment Practices for Adults With Candidemia at 9 Active Surveillance Sites-United States, 2017-2018.
Clin Infect Dis. 2021 Nov 2;73(9):1609-1616. doi: 10.1093/cid/ciab512.
5
Candida auris Outbreak in a COVID-19 Specialty Care Unit - Florida, July-August 2020.
MMWR Morb Mortal Wkly Rep. 2021 Jan 15;70(2):56-57. doi: 10.15585/mmwr.mm7002e3.
6
Regional Emergence of Candida auris in Chicago and Lessons Learned From Intensive Follow-up at 1 Ventilator-Capable Skilled Nursing Facility.
Clin Infect Dis. 2020 Dec 31;71(11):e718-e725. doi: 10.1093/cid/ciaa435.
7
Population-Based Active Surveillance for Culture-Confirmed Candidemia - Four Sites, United States, 2012-2016.
MMWR Surveill Summ. 2019 Sep 27;68(8):1-15. doi: 10.15585/mmwr.ss6808a1.
8
Management of Patients with Candida auris Fungemia at Community Hospital, Brooklyn, New York, USA, 2016-2018.
Emerg Infect Dis. 2019 Mar;25(3):601-602. doi: 10.3201/eid2503.180927.
9
Candida auris in Healthcare Facilities, New York, USA, 2013-2017.
Emerg Infect Dis. 2018 Oct;24(10):1816-1824. doi: 10.3201/eid2410.180649.
Zotero 插件